Synopsis: Lupin Limited has entered a $50 million licensing and supply agreement with Zentiva to commercialize its biosimilar Certolizumab Pegol across global markets. While Zentiva will lead sales in Europe and CIS, Lupin will manage development and supply. One of...
In a significant move within the pharmaceutical industry, a leading Indian drugmaker has expanded its diabetes care portfolio by acquiring a prominent insulin brand from Eli Lilly, a global healthcare company. This strategic acquisition, building upon an existing...
Search Topic or Keyword
Easiest Stock Screener Tool!
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
